- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05498857
Intramuscular Ephedrine in the Prevention of Hypotension in Patients Undergoing Spinal Anesthesia
Intramuscular Ephedrine in the Prevention of Hypotension in Patients Undergoing Spinal Anesthesia: a Prospective, Randomized, Double-blind, Placebo-controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subarachnoid or spinal anesthesia is an alternative and usually the first choice for many surgical procedures of the lower limbs, perineum and lower abdomen. It is a simple and safe procedure, however it can present complications such as hypotension and bradycardia. The incidence of hypotension and bradycardia is approximately 30 and 10%, respectively, during spinal anesthesia, however, the incidence of hypotension can be as high as 50 to 60% in obstetric patients.
In this sense, it is common for ephedrine, an agent with beta and alpha agonist action, to be the medication of first choice for rescuing hypotension and bradycardia after subarachnoid block, with part of its action happening by a direct mechanism and part by stimulus and indirect release. of endogenous catecholamines stored in the adrenal.
It is known that intramuscular administration has slower absorption and lower bioavailability of the drug compared to intravenous administration. Therefore, we have in our favor: a later serum peak, coinciding with the establishment of sympathetic block after spinal anesthesia, as well as more insidious effects, with less tendency to peaks and valleys and greater hemodynamic stability when compared to therapy alone. intravenous rescue. To assess this response, the main objective of the present study is to verify the hypothesis that the previous administration of ephedrine by intramuscular route reduces the incidence of hypotension induced by spinal anesthesia.
The proposal is a prospective, randomized, double-blind, placebo-controlled study in surgical procedures. Examiners responsible for evaluating patients will not have access to the agents used. Patients will be randomized through a list generated by lottery. The examiner responsible for opening the envelope, will perform the drawing, include the patient in one of the groups, write down his/her data in the random list, prepare the syringe with the medication, and deliver it to the operating room so that the following examiners will not be aware of the administered drug.
Patients will receive standard monitoring, venoclysis, intravenous midazolam as pre-anesthetic medication. Then, the study drug will be administered (ephedrine 0.3mg/kg intramuscularly or placebo). All patients received spinal anesthesia with hyperbaric bupivacaine and opioid adjuvants at the discretion of the anesthesiologist, except clonidine.
The evolution of vital signs such as systolic and mean blood pressure, heart rate, height of sensory block, incidence of adverse events such as bradycardia, tachycardia, hypertension or hypotension, nausea, vomiting, consumption of vasopressors and antiemetics will be evaluated.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Fabricio T Mendonca, MD, MSc, PhD
- Phone Number: 5561981882640
- Email: correiodofabricio@gmail.com
Study Locations
-
-
DF
-
Brasília, DF, Brazil, 70330-150
- Recruiting
- Hospital de Base do Distrito Federal
-
Contact:
- Nadja Graca, MD
- Phone Number: 556133151588
- Email: uamphbdf@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients over 18 years old, electively scaled for surgery requiring neuraxial block, with programming of spinal anesthesia.
- Physical State 1, 2 or 3 of the American Society of Anesthesiology (ASA)
Exclusion Criteria:
- Patients taking prophylactic or therapeutic anticoagulation, except respecting the allowed range;
- Patients with atrioventricular block
- Patients with cardiac arrhythmias
- Patients with heart failure;
- Patients with renal disease
- Patients with liver disease
- Patient carrying or suspecting any type of systemic infection or located in a puncture site;
- Patients who refuse to participate in the study after presenting the free and informed consent form;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Ephedrine group
Patients will receive intramuscular ephedrine 0,5 mg/kg before spinal anesthesia
|
Patients will receive prophylactic intramuscular ephedrine plus standard spinal anesthesia
Patients will receive prophylactic intramuscular saline plus standard spinal anesthesia
|
PLACEBO_COMPARATOR: Placebo group
Patients will receive intramuscular saline before spinal anesthesia
|
Patients will receive prophylactic intramuscular ephedrine plus standard spinal anesthesia
Patients will receive prophylactic intramuscular saline plus standard spinal anesthesia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with adverse events as hypotension
Time Frame: During surgery
|
Intraoperative hemodynamic stability analysis through the incidence of bradycardia, hypotension and consumed vasopressors
|
During surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fabricio T Mendonca, MD, MSc, PhD, Hospital de Base do Distrito Federal
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Hypotension
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Central Nervous System Stimulants
- Sympathomimetics
- Vasoconstrictor Agents
- Ephedrine
Other Study ID Numbers
- i.m. ephedrine
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypotension
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Edwards LifesciencesCompletedHypotension | Intraoperative Hypotension | Postoperative HypotensionNetherlands
-
James J. Peters Veterans Affairs Medical CenterCompleted
-
Attikon HospitalRecruitingHypotension During Surgery | Prevention of HypotensionGreece
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingHypotension Drug-Induced | Hypotension During Surgery
-
Universitätsklinikum Hamburg-EppendorfCompletedBlood Pressure | Postinduction Hypotension | Perioperative HypotensionGermany
-
University of ParmaUnknownHypotension During Dialysis | Dialysis HypotensionItaly
-
Peking Union Medical College HospitalRecruitingPost-induction Hypotension | Postprandial HypotensionChina
-
H. Lundbeck A/SCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Mazovia Regional Hospital in SiedlceRecruitingAnesthesia | Hypotension on Induction | Perioperative Injury | Perioperative HypotensionPoland
-
Acibadem UniversityCompletedHypotension | Intraoperative Hypotension | Post-induction Hypotension | Post Anesthesia RecoveryTurkey
Clinical Trials on Intramuscular ephedrine
-
Medical University of SilesiaCompletedMyalgia | Bruxism | Temporomandibular Disorder | PRPPoland
-
Royan InstituteUnknown
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
University of MichiganUnited States Department of DefenseRecruitingAmputation | Prostheses and ImplantsUnited States
-
The Nordic Network For Clinical Islet TransplantationUnknownType 1 Diabetes | End Stage Renal Disease
-
University of British ColumbiaNot yet recruitingMuscle Tightness
-
Whitworth UniversityRecruiting
-
University Hospital, LilleActive, not recruitingDisorder of Endocrine PancreasFrance
-
Synapse BiomedicalJohns Hopkins University; Stanford University; University Hospitals Cleveland...UnknownAmyotrophic Lateral Sclerosis (ALS)United States, France
-
MetroHealth Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted